Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

MiRNAs and long-term breast cancer survival: Evidence from the WHEL Study.

Natarajan L, Pu M, Davies SR, Vickery TL, Nelson SH, Pittman E, Parker BA, Ellis MJ, Flatt SW, Mardis ER, Marinac CR, Pierce JP, Messer K.

Cancer Epidemiol Biomarkers Prev. 2019 Jun 11. pii: cebp.1322.2018. doi: 10.1158/1055-9965.EPI-18-1322. [Epub ahead of print]

PMID:
31186261
2.

The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.

Patterson RE, Marinac CR, Sears DD, Kerr J, Hartman SJ, Cadmus-Bertram L, Villaseñor A, Flatt SW, Godbole S, Li H, Laughlin GA, Oratowski-Coleman J, Parker BA, Natarajan L.

J Natl Cancer Inst. 2018 Nov 1;110(11):1239-1247. doi: 10.1093/jnci/djy040.

3.

Insulin Resistance Improves More in Women than In Men in Association with a Weight Loss Intervention.

Badri NW, Flatt SW, Barkai HS, Pakiz B, Heath DD, Rock CL.

J Obes Weight Loss Ther. 2018;8(1). pii: 365. doi: 10.4172/2165-7904.1000365. Epub 2018 Feb 5.

4.

Walnut consumption in a weight reduction intervention: effects on body weight, biological measures, blood pressure and satiety.

Rock CL, Flatt SW, Barkai HS, Pakiz B, Heath DD.

Nutr J. 2017 Dec 4;16(1):76. doi: 10.1186/s12937-017-0304-z.

5.

A walnut-containing meal had similar effects on early satiety, CCK, and PYY, but attenuated the postprandial GLP-1 and insulin response compared to a nut-free control meal.

Rock CL, Flatt SW, Barkai HS, Pakiz B, Heath DD.

Appetite. 2017 Oct 1;117:51-57. doi: 10.1016/j.appet.2017.06.008. Epub 2017 Jun 10.

6.

The IL-6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention.

Rana BK, Flatt SW, Health DD, Pakiz B, Quintana EL, Natarajan L, Rock CL.

Nutrients. 2017 May 27;9(6). pii: E552. doi: 10.3390/nu9060552.

7.

Sleep duration and breast cancer prognosis: perspectives from the Women's Healthy Eating and Living Study.

Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE.

Breast Cancer Res Treat. 2017 Apr;162(3):581-589. doi: 10.1007/s10549-017-4140-9. Epub 2017 Feb 11.

8.

Factors Associated with Visceral Fat Loss in Response to a Multifaceted Weight Loss Intervention.

Liu FX, Flatt SW, Nichols JF, Pakiz B, Barkai HS, Wing DR, Heath DD, Rock CL.

J Obes Weight Loss Ther. 2017;7(4). pii: 346. doi: 10.4172/2165-7904.1000346. Epub 2017 Aug 14.

9.

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.

de Vries Schultink AH, Alexi X, van Werkhoven E, Madlensky L, Natarajan L, Flatt SW, Zwart W, Linn SC, Parker BA, Wu AH, Pierce JP, Huitema AD, Beijnen JH.

Breast Cancer Res Treat. 2017 Feb;161(3):567-574. doi: 10.1007/s10549-016-4083-6. Epub 2016 Dec 22.

10.

Response to "Can portion-controlled prepackaged foods promote weight loss?"

Rock CL, Flatt SW, Pakiz B, Barkai HS, Heath DD, Krumhar KC.

Obesity (Silver Spring). 2016 Nov;24(11):2260. doi: 10.1002/oby.21643. Epub 2016 Sep 12. No abstract available.

11.

Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status.

Rock CL, Flatt SW, Pakiz B, Quintana EL, Heath DD, Rana BK, Natarajan L.

Metabolism. 2016 Nov;65(11):1605-1613. doi: 10.1016/j.metabol.2016.07.008. Epub 2016 Jul 25.

12.

Randomized clinical trial of portion-controlled prepackaged foods to promote weight loss.

Rock CL, Flatt SW, Pakiz B, Barkai HS, Heath DD, Krumhar KC.

Obesity (Silver Spring). 2016 Jun;24(6):1230-7. doi: 10.1002/oby.21481.

13.

Mediation of Weight Loss and Weight Loss Maintenance through Dietary Disinhibition and Restraint.

JaKa MM, Sherwood NE, Flatt SW, Pacanowski CR, Pakiz B, Thomson CA, Rock CL.

J Obes Weight Loss Ther. 2015 Apr;5(2). pii: 253. Epub 2015 Mar 30.

15.

Prolonged Nightly Fasting and Breast Cancer Prognosis.

Marinac CR, Nelson SH, Breen CI, Hartman SJ, Natarajan L, Pierce JP, Flatt SW, Sears DD, Patterson RE.

JAMA Oncol. 2016 Aug 1;2(8):1049-55. doi: 10.1001/jamaoncol.2016.0164.

16.

Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.

Sedjo RL, Flatt SW, Byers T, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Wyatt H, Rock CL.

Support Care Cancer. 2016 Aug;24(8):3285-93. doi: 10.1007/s00520-016-3141-2. Epub 2016 Mar 5.

17.

Emotional eating is associated with weight loss success among adults enrolled in a weight loss program.

Braden A, Flatt SW, Boutelle KN, Strong D, Sherwood NE, Rock CL.

J Behav Med. 2016 Aug;39(4):727-32. doi: 10.1007/s10865-016-9728-8. Epub 2016 Mar 1.

18.

Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors.

Nelson SH, Marinac CR, Patterson RE, Nechuta SJ, Flatt SW, Caan BJ, Kwan ML, Poole EM, Chen WY, Shu XO, Pierce JP.

Breast Cancer Res Treat. 2016 Feb;155(3):551-7. doi: 10.1007/s10549-016-3694-2. Epub 2016 Feb 10.

19.

Effects of Diet Composition and Insulin Resistance Status on Plasma Lipid Levels in a Weight Loss Intervention in Women.

Le T, Flatt SW, Natarajan L, Pakiz B, Quintana EL, Heath DD, Rana BK, Rock CL.

J Am Heart Assoc. 2016 Jan 25;5(1). pii: e002771. doi: 10.1161/JAHA.115.002771.

20.

Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.

Patterson RE, Marinac CR, Natarajan L, Hartman SJ, Cadmus-Bertram L, Flatt SW, Li H, Parker B, Oratowski-Coleman J, Villaseñor A, Godbole S, Kerr J.

Contemp Clin Trials. 2016 Mar;47:64-71. doi: 10.1016/j.cct.2015.12.009. Epub 2015 Dec 17.

21.

A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.

Nechuta S, Chen WY, Cai H, Poole EM, Kwan ML, Flatt SW, Patterson RE, Pierce JP, Caan BJ, Ou Shu X.

Int J Cancer. 2016 May 1;138(9):2088-97. doi: 10.1002/ijc.29940. Epub 2015 Dec 9.

22.

Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M, Pakiz B, Parker BA, Sedjo RL, Wyatt H.

J Clin Oncol. 2015 Oct 1;33(28):3169-76. doi: 10.1200/JCO.2015.61.1095. Epub 2015 Aug 17.

23.

Baseline Depressive Symptoms, Completion of Study Assessments, and Behavior Change in a Long-Term Dietary Intervention Among Breast Cancer Survivors.

Wang JB, Pierce JP, Ayala GX, Cadmus-Bertram LA, Flatt SW, Madanat H, Newman VA, Nichols JF, Natarajan L.

Ann Behav Med. 2015 Dec;49(6):819-27. doi: 10.1007/s12160-015-9716-1.

24.

Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study.

Liu FX, Flatt SW, Pakiz B, Sedjo RL, Wolin KY, Blair CK, Demark-Wahnefried W, Rock CL.

Support Care Cancer. 2016 Jan;24(1):173-180. doi: 10.1007/s00520-015-2761-2. Epub 2015 May 15.

25.

Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial.

Pakiz B, Ganz PA, Sedjo RL, Flatt SW, Demark-Wahnefried W, Liu J, Wolin KY, Rock CL.

Psychooncology. 2016 Feb;25(2):142-9. doi: 10.1002/pon.3820. Epub 2015 Apr 29.

26.

Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial.

Rock CL, Flatt SW, Pakiz B, Taylor KS, Leone AF, Brelje K, Heath DD, Quintana EL, Sherwood NE.

Diabetes Care. 2014 Jun;37(6):1573-80. doi: 10.2337/dc13-2900. Epub 2014 Apr 23.

27.

Mechanisms of association between physical functioning and breast cancer mortality: evidence from the Women's Healthy Eating and Living Study.

Marinac C, Patterson RE, Villasenor A, Flatt SW, Pierce JP.

J Cancer Surviv. 2014 Sep;8(3):402-9. doi: 10.1007/s11764-013-0334-2. Epub 2014 Feb 26.

28.

Predictors of improvement in cardiometabolic risk factors with weight loss in women.

Dow CA, Thomson CA, Flatt SW, Sherwood NE, Pakiz B, Rock CL.

J Am Heart Assoc. 2013 Dec 18;2(6):e000152. doi: 10.1161/JAHA.113.000152.

29.

Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.

Pierce JP, Patterson RE, Senger CM, Flatt SW, Caan BJ, Natarajan L, Nechuta SJ, Poole EM, Shu XO, Chen WY.

J Natl Cancer Inst. 2014 Jan;106(1):djt359. doi: 10.1093/jnci/djt359. Epub 2013 Dec 7.

30.

Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study.

Villaseñor A, Flatt SW, Marinac C, Natarajan L, Pierce JP, Patterson RE.

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):189-99. doi: 10.1158/1055-9965.EPI-13-0852. Epub 2013 Nov 12.

31.

Endogenous estradiol is not associated with poor physical health in postmenopausal breast cancer survivors.

Su HI, Sue LY, Flatt SW, Natarajan L, Patterson RE, Pierce JP.

J Womens Health (Larchmt). 2013 Dec;22(12):1043-8. doi: 10.1089/jwh.2013.4375. Epub 2013 Oct 10.

32.

Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project.

Nechuta S, Caan BJ, Chen WY, Kwan ML, Lu W, Cai H, Poole EM, Flatt SW, Zheng W, Pierce JP, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1451-6. doi: 10.1158/1055-9965.EPI-13-0446. Epub 2013 Jun 13.

33.

Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project.

Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W, Kwan ML, Nechuta SJ, Pierce JP, Chen WY.

Breast Cancer Res Treat. 2013 Jun;139(2):529-37. doi: 10.1007/s10549-013-2548-4. Epub 2013 May 10.

34.

Correlates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study.

Jacobs ET, Thomson CA, Flatt SW, Newman VA, Rock CL, Pierce JP.

Nutr Cancer. 2013;65(2):188-94. doi: 10.1080/01635581.2013.756531.

35.

Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.

Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, Williams K, Bardwell WA, Heath DD, Nichols JF.

Clin Breast Cancer. 2013 Jun;13(3):188-95. doi: 10.1016/j.clbc.2012.12.002. Epub 2013 Jan 29.

36.

Impact of breast cancer on anti-mullerian hormone levels in young women.

Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ.

Breast Cancer Res Treat. 2013 Jan;137(2):571-7. doi: 10.1007/s10549-012-2361-5. Epub 2012 Dec 9. Erratum in: Breast Cancer Res Treat. 2013 Apr;138(3):975.

37.

Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.

Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta SJ, Poole EM, Holmes MD, Patterson RE, Shu XO, Pierce JP, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):32-41. doi: 10.1158/1055-9965.EPI-12-1022. Epub 2012 Nov 13.

38.

Associations of soluble fiber, whole fruits/vegetables, and juice with plasma Beta-carotene concentrations in a free-living population of breast cancer survivors.

Kolodziejczyk JK, Flatt SW, Natarajan L, Patterson R, Pierce JP, Norman GJ.

Women Health. 2012;52(8):731-43. doi: 10.1080/03630242.2012.728189.

39.

Weight change and survival after breast cancer in the after breast cancer pooling project.

Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP Jr, Holmes MD, Chen WY.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1260-71. doi: 10.1158/1055-9965.EPI-12-0306. Epub 2012 Jun 13. Erratum in: Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):319.

40.

Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women.

Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, Flatt SW, Zheng Y, Zheng W, Pierce JP, Shu XO.

Am J Clin Nutr. 2012 Jul;96(1):123-32. doi: 10.3945/ajcn.112.035972. Epub 2012 May 30.

41.

Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.

Caan BJ, Emond JA, Su HI, Patterson RE, Flatt SW, Gold EB, Newman VA, Rock CL, Thomson CA, Pierce JP.

J Clin Oncol. 2012 May 1;30(13):1492-7. doi: 10.1200/JCO.2011.36.8597. Epub 2012 Mar 19.

42.

Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial.

Thomson CA, Morrow KL, Flatt SW, Wertheim BC, Perfect MM, Ravia JJ, Sherwood NE, Karanja N, Rock CL.

Obesity (Silver Spring). 2012 Jul;20(7):1419-25. doi: 10.1038/oby.2012.62. Epub 2012 Mar 8.

43.

Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women.

Rock CL, Emond JA, Flatt SW, Heath DD, Karanja N, Pakiz B, Sherwood NE, Thomson CA.

Obesity (Silver Spring). 2012 Nov;20(11):2296-301. doi: 10.1038/oby.2012.57. Epub 2012 Mar 8.

44.

The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics.

Nechuta SJ, Caan BJ, Chen WY, Flatt SW, Lu W, Patterson RE, Poole EM, Kwan ML, Chen Z, Weltzien E, Pierce JP, Shu XO.

Cancer Causes Control. 2011 Sep;22(9):1319-31. doi: 10.1007/s10552-011-9805-9. Epub 2011 Jun 28.

45.

Evaluation of 25-hydroxyvitamin D quantification using a commercial HPLC kit method.

Heath DD, Flatt SW, Thomson CA, Jacobs ET, Pruitt MA, Rock CL.

Br J Biomed Sci. 2011;68(2):86-91. No abstract available.

PMID:
21706920
46.

Long-term course of pain in breast cancer survivors: a 4-year longitudinal study.

Rief W, Bardwell WA, Dimsdale JE, Natarajan L, Flatt SW, Pierce JP.

Breast Cancer Res Treat. 2011 Nov;130(2):579-86. doi: 10.1007/s10549-011-1614-z. Epub 2011 Jun 9.

47.

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

Madlensky L, Natarajan L, Tchu S, Pu M, Mortimer J, Flatt SW, Nikoloff DM, Hillman G, Fontecha MR, Lawrence HJ, Parker BA, Wu AH, Pierce JP.

Clin Pharmacol Ther. 2011 May;89(5):718-25. doi: 10.1038/clpt.2011.32. Epub 2011 Mar 23.

48.

Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors.

Pakiz B, Flatt SW, Bardwell WA, Rock CL, Mills PJ.

Int J Behav Med. 2011 Dec;18(4):333-41. doi: 10.1007/s12529-010-9079-8.

49.

Was race a factor in the outcomes of the Women's Health Eating and Living Study?

Paxton RJ, Jones LA, Chang S, Hernandez M, Hajek RA, Flatt SW, Natarajan L, Pierce JP.

Cancer. 2011 Aug 15;117(16):3805-13. doi: 10.1002/cncr.25957. Epub 2011 Feb 11.

50.

IGF1 and risk of additional breast cancer in the WHEL study.

Al-Delaimy WK, Flatt SW, Natarajan L, Laughlin GA, Rock CL, Gold EB, Caan BJ, Parker BA, Pierce JP.

Endocr Relat Cancer. 2011 Mar 3;18(2):235-44. doi: 10.1530/ERC-10-0121. Print 2011 Apr.

PMID:
21263044

Supplemental Content

Loading ...
Support Center